India

Prices Of Diabetes, Heart & Kidney Drugs Could Be Slashed

By
OB Bureau

New Delhi: The government is planning to bring down the prices of critical drugs by fixing trade margins, according to News18.com.

Trade margins are the difference between the price to trade for manufacturers and the price to patients as the maximum retail price (MRP).

“The efforts are to reduce prices of drugs used for the treatment of diabetic, cardiovascular diseases, and chronic kidney diseases,” the report said quoting a top official in the ministry of health and family welfare.

The trade margin will be rationalised in a phased manner as it enables better execution and gives time to the industry to accommodate changes, the source said while hinting that the move is expected to be announced soon.

“For instance, we first slashed the margins in the anti-cancer category. Similarly, this time, we will announce the slashing of the trade margins of a particular category of drugs such as anti-diabetic or for kidney diseases,” said the source.

Drug price watchdog National Pharmaceutical Pricing Authority (NPPA) has been working on the plan for the past several months.

In 2018-19, the NPPA had put a cap on trade margins of 42 select non-scheduled anti-cancer medicines. Union health minister Mansukh Mandaviya had said in the Lok Sabha that the move resulted in the reduction of up to 90% of the MRP of 526 brands of these medicines.

This time, the source said, NPPA has conducted a study and the rationalisation will be based on the inputs from the same.

According to the study on TMR analysis conducted by NPPA, a trader’s margin moves higher with the price of a tablet.

It found that, for instance, if a tablet is priced up to Rs 2, in the majority of the brands, the margin is up to 50%; whereas if its cost is between Rs 15 and Rs 25, the margin is less than 40%.

At least 2.97% of the medicines in the Rs 50-100 per tablet category have trade margins between 50% and 100%, 1.25% in the category have margins between 100% and 200%, and 2.41% have margins between 200% and 500%.

As per NPPA’s presentation, in the case of medicines priced above Rs 100 per tablet, considered the costliest category, 8% have margins around 200% to 500%, 2.7% have margins around 500-1000%, and 1.48% have more than 1000% margins.

OB Bureau

Recent Posts

Another Stone Falls From Jagannath Temple At Khallikote In Odisha’s Ganjam

Berhampur: A stone weighing 2 kg fell from the ‘Singhadwara Gumuta’ of the Lord Jagannath…

November 14, 2024

Sunita Williams Dismisses Rumours About Weight Loss, Explains Her ‘Sunken Cheeks’

New Delhi: Recent pictures of Space Station Commander Sunita Williams from the International Space Station…

November 14, 2024

Payal Rohatgi Calls Out Rupali Ganguly For Dating A Married Man

Mumbai: Actress Rupali Ganguly recently filed a Rs 50 crore defamation case against her stepdaughter…

November 14, 2024

National Hockey: Odisha To Clash With Manipur In Semifinals

Chennai: Odisha will face Manipur in the semifinals of the 14th Hockey India Senior Men’s…

November 14, 2024

India To Push Canada For Extradition Of Arrested Khalistani Terrorist Arsh Dalla

New Delhi: India will again ask Canada for the extradition of designated Khalistani terrorist Arshdeep Singh…

November 14, 2024

School Dropout From West Bengal Arrested For Practising As Ayurvedic Doctor In Odisha’s Berhampur

Berhampur: Police have arrested a man from West Bengal for allegedly claiming himself to be…

November 14, 2024

Manoj Bajpayee Recalls Staying In ‘Hell’, Experiencing Starvation

Mumbai: Carving a niche for himself in Bollywood was not a cakewalk for ‘The Family…

November 14, 2024

After Disapproving Of Ranveer, Mukesh Khanna Rejects Tiger Shroff For ‘Shakitmaan’

Mumbai: Mukesh Khanna’s Indian superhero series ‘Shaktimaan’ has been making headlines for quite some time…

November 14, 2024